Optimal care of inhibitor patients during surgery

European Journal of Haematology

Volumn 61, Issue SUPPL.63, 1998, Pages 15-17

  Vermylen, Jos ^a   Peerlinck, Kathelijne ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Factor vlll inhibitor; Haemophilia; Surgery

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; RECOMBINANT PROTEIN; ANTIFIBRINOLYTIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ARTICLE; BLOOD; HEMOPHILIA A; HIP ARTHROPLASTY; HUMAN; IMMUNOLOGY; INFECTION; SURGERY; BLEEDING; CASE REPORT; CONFERENCE PAPER; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; FIBRINOLYSIS; HEMOPHILIA; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; THROMBOPHLEBITIS;

ANTIBODIES; ARTHROPLASTY, REPLACEMENT, HIP; FACTOR IX; FACTOR VIIA; FACTOR VIII; HEMOPHILIA A; HUMANS; PROSTHESIS-RELATED INFECTIONS; RECOMBINANT PROTEINS; SURGICAL PROCEDURES, OPERATIVE;

EID: 0031673156     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01105.x     Document Type: Article

References (8)

1. Hedner U, Glazer S, Pingel K, et al. Successful use of recombinant factor VIIa in a patient with severe haemophilia A during synovectomy (letter). Lancet 1988;ii:1193.
2. Ingerslev J, Friedman D, Gastineau D, et al. Major surgery in haemophilia patients with inhibitors using recombinant factor VIIa. Haemostasis 1996;26(suppl 1):131-134.
3. Lusher JM, Ingerslev J,Roberts H, Hedner U. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinol 1998;9:119-228.
4. Schulman S, D'oiron R, Martinowitz U,et al. Experiences with continuous infusion of recombinant activated factor VII. Blood Coagul Fibrinol 1998;9(suppl l):S97-S101.
5. Gilchrist G, Cooper HA, Hoots WK, Shapiro AD. Effectiveness of recombinant activated factor VII in producing surgical haemostasis in patients with inhibitors to factor VIII or FIX. a randomized, double-blind study comparing two dose levels (abstract). Blood Coagul Fibrinol 1998;9(suppl 1):S154.
6. Lindley CM, Sawyer WT, Macik BG, et al. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 1994;55:638-648.
7. Schulman S, Bech J Ensen M, Varon D, et al. Feasibility of using recombinant factor VIIa in continuous infusion. Thromb Haemost 1996;75:432-436.
8. Schulman S for the rFVIIa-CI GROUP. Safety, efficacy and lessons from continuous infusion with rFVIIa. Haemophilia 1998;4:564-567.